Contents

The document provided an overview of the current utilization of biologicals in various medical and cosmetic applications. It discussed the increasing use of biologics, defined by the FDA as products composed of sugars, proteins, nucleic acids, or living entities like cells and tissues. Topics included the use of cosmeceuticals for skin aging, the biology of hair growth and pigmentation, the role of stem cells in dermatology, and the application of platelet-rich plasma (PRP) for skin rejuvenation and hair loss. The document highlighted the potential of PRP in treating androgenetic alopecia and alopecia areata, noting positive clinical responses and the convenience of treatment. It also covered the use of mesenchymal stem cells and stromal vascular fraction in hair loss and skin rejuvenation, emphasizing the need for further research to explore their efficacy and safety.